DNLI
Price
$26.52
Change
-$0.00 (-0.00%)
Updated
Oct 9 closing price
20 days until earnings call
JANX
Price
$46.00
Change
-$0.00 (-0.00%)
Updated
Oct 9 closing price
26 days until earnings call
Ad is loading...

DNLI vs JANX

Header iconDNLI vs JANX Comparison
Open Charts DNLI vs JANXBanner chart's image
Denali Therapeutics
Price$26.52
Change-$0.00 (-0.00%)
Volume$410.42K
CapitalizationN/A
Janux Therapeutics
Price$46.00
Change-$0.00 (-0.00%)
Volume$447.35K
CapitalizationN/A
View a ticker or compare two or three
DNLI vs JANX Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
DNLI vs. JANX commentary
Oct 11, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a StrongSell and JANX is a Buy.

COMPARISON
Comparison
Oct 11, 2024
Stock price -- (DNLI: $26.52 vs. JANX: $46.00)
Brand notoriety: DNLI and JANX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 45% vs. JANX: 77%
Market capitalization -- DNLI: $4.17B vs. JANX: $2.37B
DNLI [@Biotechnology] is valued at $4.17B. JANX’s [@Biotechnology] market capitalization is $2.37B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileJANX’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • JANX’s FA Score: 0 green, 5 red.
According to our system of comparison, JANX is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 4 TA indicator(s) are bullish while JANX’s TA Score has 5 bullish TA indicator(s).

  • DNLI’s TA Score: 4 bullish, 4 bearish.
  • JANX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, JANX is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а -8.65% price change this week, while JANX (@Biotechnology) price change was +5.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

DNLI is expected to report earnings on Mar 03, 2025.

JANX is expected to report earnings on Mar 07, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($4.17B) has a higher market cap than JANX($2.37B). JANX YTD gains are higher at: 328.705 vs. DNLI (23.579). JANX has higher annual earnings (EBITDA): -63.86M vs. DNLI (-486.71M). DNLI has more cash in the bank: 896M vs. JANX (646M). JANX has less debt than DNLI: JANX (23.8M) vs DNLI (48.8M). JANX has higher revenues than DNLI: JANX (15.1M) vs DNLI (1.27M).
DNLIJANXDNLI / JANX
Capitalization4.17B2.37B176%
EBITDA-486.71M-63.86M762%
Gain YTD23.579328.7057%
P/E RatioN/AN/A-
Revenue1.27M15.1M8%
Total Cash896M646M139%
Total Debt48.8M23.8M205%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
86
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIJANX
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 14 days ago
80%
Bullish Trend 2 days ago
87%
Declines
ODDS (%)
Bearish Trend 10 days ago
78%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL229.543.77
+1.67%
Apple
SPY577.143.97
+0.69%
SPDR® S&P 500® ETF Trust
GME20.50-0.21
-1.01%
GameStop Corp
TSLA241.05-3.45
-1.41%
Tesla
BTC.X60582.100000-1549.867200
-2.49%
Bitcoin cryptocurrency

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with VKTX. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then VKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
+2.38%
VKTX - JANX
65%
Loosely correlated
-6.06%
DNLI - JANX
57%
Loosely correlated
-0.79%
LGND - JANX
48%
Loosely correlated
+0.19%
BEAM - JANX
45%
Loosely correlated
+0.77%
CDXS - JANX
43%
Loosely correlated
+0.65%
More